Nothing Special   »   [go: up one dir, main page]

ATE97324T1 - Verwendung von amphipatischen molekuelen zur radiodarstellung und therapie mittels monoklonaler oder polyklonaler antikoerperkonjugate. - Google Patents

Verwendung von amphipatischen molekuelen zur radiodarstellung und therapie mittels monoklonaler oder polyklonaler antikoerperkonjugate.

Info

Publication number
ATE97324T1
ATE97324T1 AT86306437T AT86306437T ATE97324T1 AT E97324 T1 ATE97324 T1 AT E97324T1 AT 86306437 T AT86306437 T AT 86306437T AT 86306437 T AT86306437 T AT 86306437T AT E97324 T1 ATE97324 T1 AT E97324T1
Authority
AT
Austria
Prior art keywords
radiography
monoclonal
therapy
polyclonal antibody
antibody conjugates
Prior art date
Application number
AT86306437T
Other languages
English (en)
Inventor
A Charles Morgan Jr
Gowsala Pavanasasivam
Original Assignee
Neorx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neorx Corp filed Critical Neorx Corp
Application granted granted Critical
Publication of ATE97324T1 publication Critical patent/ATE97324T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86306437T 1985-08-20 1986-08-20 Verwendung von amphipatischen molekuelen zur radiodarstellung und therapie mittels monoklonaler oder polyklonaler antikoerperkonjugate. ATE97324T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76749385A 1985-08-20 1985-08-20
EP86306437A EP0213881B1 (de) 1985-08-20 1986-08-20 Verwendung von amphipatischen Molekülen zur Radiodarstellung und Therapie mittels monoklonaler oder polyklonaler Antikörperkonjugate

Publications (1)

Publication Number Publication Date
ATE97324T1 true ATE97324T1 (de) 1993-12-15

Family

ID=25079669

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86306437T ATE97324T1 (de) 1985-08-20 1986-08-20 Verwendung von amphipatischen molekuelen zur radiodarstellung und therapie mittels monoklonaler oder polyklonaler antikoerperkonjugate.

Country Status (7)

Country Link
EP (1) EP0213881B1 (de)
JP (1) JPS62181224A (de)
AT (1) ATE97324T1 (de)
CA (1) CA1306194C (de)
DE (1) DE3689299T2 (de)
DK (1) DK398086A (de)
NO (1) NO168989C (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4926869A (en) * 1986-01-16 1990-05-22 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US4946675A (en) * 1987-05-27 1990-08-07 Xoma Corporation Hepatic blocking agents
WO2022104147A1 (en) * 2020-11-13 2022-05-19 Beckman Coulter, Inc. Additives for reducing non-specific interactions between fluorescent polymer conjugates and cells in a biological sample
CN104370997B (zh) * 2014-09-24 2018-07-31 陈辉 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927103A1 (de) * 1978-10-06 1980-04-17 Baxter Travenol Lab Optisches verfahren zur bestimmung von endotoxin
US4460559A (en) * 1980-03-03 1984-07-17 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers

Also Published As

Publication number Publication date
NO168989C (no) 1992-04-29
NO863338D0 (no) 1986-08-19
EP0213881B1 (de) 1993-11-18
DK398086A (da) 1987-02-21
DE3689299D1 (de) 1993-12-23
EP0213881A2 (de) 1987-03-11
NO863338L (no) 1987-02-23
DE3689299T2 (de) 1994-03-10
EP0213881A3 (en) 1987-09-16
JPS62181224A (ja) 1987-08-08
DK398086D0 (da) 1986-08-20
NO168989B (no) 1992-01-20
CA1306194C (en) 1992-08-11

Similar Documents

Publication Publication Date Title
DK499086A (da) Konjugater af trichothecen og anvendelse af samme som terapeutisk substans
ATE162403T1 (de) Modifizierte antikörper mit kontrollierter clearance-zeit
DE69729283D1 (de) GLYKOSYLIERTE IgG ANTIKÖRPER
FI950062A (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
DE3687736D1 (de) Monoklonale antikoerper gegen humanen brustkrebs, korrespondierende hybridome, deren herstellung und verwendung.
ES2169864T3 (es) Anticuerpos monoclonales anti-endoglina y su uso en terapia anti-angiogenesis.
NO901986L (no) Nytt antistoff-leveringssystem for biologisk respons-modifiserende midler.
FI843930A0 (fi) Maerkta konjugat av metalltionein och maolsoekande biologiskt aktiva molekyler.
DK651088D0 (da) Konjugater af laegemidler og monoklonale antistoffer
FI906368A0 (fi) Makrocykliska bifunktionella kelatbildare, komplex daerav och deras antikroppkonjugat
EP0554356A4 (en) A monoclonal antibody
BR9607171A (pt) Anticorpos monoclonais anti-cd6 e usos dos mesmos
KR900701321A (ko) 암 진단 및 치료용 면역접합체
DK0433088T3 (da) Monoklonale antistoffer, der reagerer med et humant atheromaassocieret antigen
ATE120372T1 (de) Antikörper für die antilymphozyten- antikörpertherapie.
ATE97324T1 (de) Verwendung von amphipatischen molekuelen zur radiodarstellung und therapie mittels monoklonaler oder polyklonaler antikoerperkonjugate.
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
ATE178493T1 (de) Stabilisierte antikörperfragmente
DE69012034D1 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.
ES1032013U (es) Dispositivo electropolarizado.
TW221711B (en) N-AFP monoclonal antibody and method of preparation thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties